Clinical Trial Update: Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients [Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 3 multicenter trial evaluating lumateperone for pediatric bipolar depression. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Caplyta (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: RECRUITING